Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring TrendingStockAlerts · Jan 1, 2026
Equanimity AI to Debut Beacon, an AI-Operated Pain OS, at NANS 2026 TrendingStockAlerts · Dec 31, 2025
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596 TrendingStockAlerts · Dec 30, 2025
Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study TrendingStockAlerts · Dec 29, 2025
From Follower to Force: China's Biotech Sector Enters the Global Clinical Mainstream TrendingStockAlerts · Dec 28, 2025
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly TrendingStockAlerts · Dec 27, 2025
Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy TrendingStockAlerts · Dec 26, 2025
A Slice of Humble Pie: How One Farmer's Harvest-Time Tradition Is Lifting Up Her Community TrendingStockAlerts · Dec 25, 2025
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach TrendingStockAlerts · Dec 24, 2025
T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma TrendingStockAlerts · Dec 23, 2025
New York State's 2025 Emerging Technology Advisory Board Releases Final Report to Boost Biotech Innovation, Commercialization and Public Health Impact TrendingStockAlerts · Dec 22, 2025
Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint TrendingStockAlerts · Dec 21, 2025
